202 related articles for article (PubMed ID: 10973963)
1. Identification of a functional domain in a GADD45-mediated G2/M checkpoint.
Yang Q; Manicone A; Coursen JD; Linke SP; Nagashima M; Forgues M; Wang XW
J Biol Chem; 2000 Nov; 275(47):36892-8. PubMed ID: 10973963
[TBL] [Abstract][Full Text] [Related]
2. GADD45-induced cell cycle G2-M arrest associates with altered subcellular distribution of cyclin B1 and is independent of p38 kinase activity.
Jin S; Tong T; Fan W; Fan F; Antinore MJ; Zhu X; Mazzacurati L; Li X; Petrik KL; Rajasekaran B; Wu M; Zhan Q
Oncogene; 2002 Dec; 21(57):8696-704. PubMed ID: 12483522
[TBL] [Abstract][Full Text] [Related]
3. The GADD45 inhibition of Cdc2 kinase correlates with GADD45-mediated growth suppression.
Jin S; Antinore MJ; Lung FD; Dong X; Zhao H; Fan F; Colchagie AB; Blanck P; Roller PP; Fornace AJ; Zhan Q
J Biol Chem; 2000 Jun; 275(22):16602-8. PubMed ID: 10747892
[TBL] [Abstract][Full Text] [Related]
4. A p21(waf1)-independent pathway for inhibitory phosphorylation of cyclin-dependent kinase p34(cdc2) and concomitant G(2)/M arrest by the chemopreventive flavonoid apigenin.
McVean M; Weinberg WC; Pelling JC
Mol Carcinog; 2002 Jan; 33(1):36-43. PubMed ID: 11807956
[TBL] [Abstract][Full Text] [Related]
5. Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45.
Zhan Q; Antinore MJ; Wang XW; Carrier F; Smith ML; Harris CC; Fornace AJ
Oncogene; 1999 May; 18(18):2892-900. PubMed ID: 10362260
[TBL] [Abstract][Full Text] [Related]
6. GADD45 induction of a G2/M cell cycle checkpoint.
Wang XW; Zhan Q; Coursen JD; Khan MA; Kontny HU; Yu L; Hollander MC; O'Connor PM; Fornace AJ; Harris CC
Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3706-11. PubMed ID: 10097101
[TBL] [Abstract][Full Text] [Related]
7. The central region of Gadd45 is required for its interaction with p21/WAF1.
Zhao H; Jin S; Antinore MJ; Lung FD; Fan F; Blanck P; Roller P; Fornace AJ; Zhan Q
Exp Cell Res; 2000 Jul; 258(1):92-100. PubMed ID: 10912791
[TBL] [Abstract][Full Text] [Related]
8. p53-independent induction of p21 (WAF1/CIP1), reduction of cyclin B1 and G2/M arrest by the isoflavone genistein in human prostate carcinoma cells.
Choi YH; Lee WH; Park KY; Zhang L
Jpn J Cancer Res; 2000 Feb; 91(2):164-73. PubMed ID: 10761703
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the G2/M transition by p53.
Taylor WR; Stark GR
Oncogene; 2001 Apr; 20(15):1803-15. PubMed ID: 11313928
[TBL] [Abstract][Full Text] [Related]
10. Gadd45 in the response of hematopoietic cells to genotoxic stress.
Liebermann DA; Hoffman B
Blood Cells Mol Dis; 2007; 39(3):329-35. PubMed ID: 17659913
[TBL] [Abstract][Full Text] [Related]
11. Involvement of the interaction between p21 and proliferating cell nuclear antigen for the maintenance of G2/M arrest after DNA damage.
Ando T; Kawabe T; Ohara H; Ducommun B; Itoh M; Okamoto T
J Biol Chem; 2001 Nov; 276(46):42971-7. PubMed ID: 11559705
[TBL] [Abstract][Full Text] [Related]
12. Characterization of p21Cip1/Waf1 peptide domains required for cyclin E/Cdk2 and PCNA interaction.
Chen IT; Akamatsu M; Smith ML; Lung FD; Duba D; Roller PP; Fornace AJ; O'Connor PM
Oncogene; 1996 Feb; 12(3):595-607. PubMed ID: 8637717
[TBL] [Abstract][Full Text] [Related]
13. PPARgamma ligands inhibit cholangiocarcinoma cell growth through p53-dependent GADD45 and p21 pathway.
Han C; Demetris AJ; Michalopoulos GK; Zhan Q; Shelhamer JH; Wu T
Hepatology; 2003 Jul; 38(1):167-77. PubMed ID: 12829999
[TBL] [Abstract][Full Text] [Related]
14. The role of Cdc2 feedback loop control in the DNA damage checkpoint in mammalian cells.
Poon RY; Chau MS; Yamashita K; Hunter T
Cancer Res; 1997 Nov; 57(22):5168-78. PubMed ID: 9371520
[TBL] [Abstract][Full Text] [Related]
15. Genistein-induced G2/M arrest is associated with the inhibition of cyclin B1 and the induction of p21 in human breast carcinoma cells.
Choi YH; Zhang L; Lee WH; Park KY
Int J Oncol; 1998 Aug; 13(2):391-6. PubMed ID: 9664138
[TBL] [Abstract][Full Text] [Related]
16. Loss of p53 induces M-phase retardation following G2 DNA damage checkpoint abrogation.
Minemoto Y; Uchida S; Ohtsubo M; Shimura M; Sasagawa T; Hirata M; Nakagama H; Ishizaka Y; Yamashita K
Arch Biochem Biophys; 2003 Apr; 412(1):13-9. PubMed ID: 12646262
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of human Gadd45γ [corrected] reveals an active dimer.
Zhang W; Fu S; Liu X; Zhao X; Zhang W; Peng W; Wu C; Li Y; Li X; Bartlam M; Zeng ZH; Zhan Q; Rao Z
Protein Cell; 2011 Oct; 2(10):814-26. PubMed ID: 22058036
[TBL] [Abstract][Full Text] [Related]
18. The C-terminal region of p21SDI1/WAF1/CIP1 is involved in proliferating cell nuclear antigen binding but does not appear to be required for growth inhibition.
Nakanishi M; Robetorye RS; Pereira-Smith OM; Smith JR
J Biol Chem; 1995 Jul; 270(29):17060-3. PubMed ID: 7615495
[TBL] [Abstract][Full Text] [Related]
19. p21 inhibits Thr161 phosphorylation of Cdc2 to enforce the G2 DNA damage checkpoint.
Smits VA; Klompmaker R; Vallenius T; Rijksen G; Mäkela TP; Medema RH
J Biol Chem; 2000 Sep; 275(39):30638-43. PubMed ID: 10913154
[TBL] [Abstract][Full Text] [Related]
20. Deregulation of p53/p21Cip1/Waf1 pathway contributes to polyploidy and apoptosis of E1A+cHa-ras transformed cells after gamma-irradiation.
Bulavin DV; Tararova ND; Aksenov ND; Pospelov VA; Pospelova TV
Oncogene; 1999 Oct; 18(41):5611-9. PubMed ID: 10523840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
